Table 3.
Complications of 22 patients∗ receiving 23 gracilis flaps for sarcoma reconstruction, 1998 to 2017.
| Patient no. | No. of complications (type) | ||
|---|---|---|---|
| Major | Minor | Sarcoma recurrence† | |
| 1 | 0 | 2 (partial skin-graft loss, partial flap necrosis) | |
| 2 | 0 | 1 (superficial infection) | 1 |
| 3 | 3 (infection, unplanned operation (incision and drainage), flap loss) | 0 | |
| 5 | 0 | 1 (partial skin-graft loss) | 1 |
| 6 | 2 (unplanned operation (attempted salvage), flap loss) | 0 | |
| 8 | 0 | 1 (planned reoperation (recipient scar revision)) | |
| 9 | 1 (unplanned operation (hematoma evacuation)) | 2 (superficial infection, partial flap necrosis) | |
| 10 | 0 | 1 (planned reoperation (recipient scar revision)) | 1 |
| 12 | 0 | 2 (superficial infection, partial skin-graft loss) | |
| 15 | 1 (unplanned operation (successful salvage)) | 0 | |
| 16 | 0 | 1 (partial flap necrosis) | |
| 17 | 0 | 1 (superficial infection) | |
| 18 | 0 | 1 (planned reoperation (donor scar revision)) | |
| 19 | 2 (infection, amputation) | 0 | |
| 20 | 0 | 2 (fluid collection, partial skin-graft loss) | |
| 21 | 1 (amputation) | 1 (planned reoperation (amputation for cancer recurrence)) | |
| Total events | 8 | 16 | 3 |
| Patients (%) | 6 (27) | 12 (55) | 3 (14) |
IV, intravenous. ∗Six patients had no complications and are not listed in table. †There were no cases of recurrence at the site of gracilis flap harvest (mean follow-up, 53 months (range 9–156 months)).